A system for intensity modulated dose plan verification based on an experimental pencil beam kernel obtained by deconvolution
Related Experiment Video
Updated: Jul 7, 2026

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
Juan Diego Azcona1, Javier Burguete
1Department of Oncology, Division of Radiation Physics, Clínica Universitaria, Universidad de Navarra, Avda. Pío XII, 36, 31008 Pamplona, Navarra, Spain. jazcona@unav.es
Abstract:
The number of intensity modulated radiation therapy (IMRT) procedures is continuously growing worldwide and it is necessary to develop tools for patient specific quality assurance (QA) that avoid using machine time that could be employed in treating additional patients. One way of achieving this goal is to perform a multileaf collimator quality assurance periodically in the linear accelerator and check the treatment planning system (TPS) calculation by employing an independent calculation system. Within the work frame of the pencil beam kernel approach, a new system was developed for obtaining an experimental kernel. This new technique is based on a deconvolution procedure using the Hankel transform. The resulting kernel is obtained in a way completely independent of those employed in commercial treatment planning systems, usually calculated by Monte Carlo simulations. Also provided are comparisons between calculated and measured doses with radiographic film, linear array of diodes, and ionization chamber. Measurements taken in polystyrene and water for clinical IMRT plans demonstrate that this method can calculate IMRT dose distributions, as well as treatment times, with great accuracy. Apart from other applications, it can be used as a double-check algorithm for IMRT QA.
More Related Videos
08:34Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022